Free Trial

Clorox (NYSE:CLX) Price Target Lowered to $155.00 at Wells Fargo & Company

Clorox logo with Consumer Staples background
Remove Ads

Clorox (NYSE:CLX - Get Free Report) had its price objective cut by Wells Fargo & Company from $161.00 to $155.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Wells Fargo & Company's price target indicates a potential upside of 7.82% from the company's previous close.

CLX has been the topic of several other research reports. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Barclays decreased their price target on shares of Clorox from $140.00 to $139.00 and set an "underweight" rating on the stock in a report on Thursday, March 27th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $159.00.

Remove Ads

Read Our Latest Stock Analysis on Clorox

Clorox Price Performance

CLX stock traded down $4.93 during mid-day trading on Wednesday, reaching $143.76. 2,292,858 shares of the company traded hands, compared to its average volume of 1,283,012. Clorox has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market capitalization of $17.71 billion, a P/E ratio of 39.28, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a fifty day moving average price of $150.06 and a 200-day moving average price of $158.44.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company earned $2.16 earnings per share. As a group, analysts anticipate that Clorox will post 7.15 earnings per share for the current year.

Institutional Investors Weigh In On Clorox

Institutional investors have recently bought and sold shares of the stock. Norges Bank bought a new stake in Clorox in the fourth quarter valued at approximately $259,041,000. FMR LLC raised its holdings in Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company's stock valued at $221,163,000 after buying an additional 585,526 shares during the last quarter. Marshall Wace LLP boosted its position in Clorox by 549.8% during the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock valued at $88,144,000 after buying an additional 459,203 shares during the period. ExodusPoint Capital Management LP grew its holdings in Clorox by 187.9% in the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock worth $113,508,000 after acquiring an additional 456,114 shares during the last quarter. Finally, Man Group plc increased its position in shares of Clorox by 154.6% in the fourth quarter. Man Group plc now owns 570,503 shares of the company's stock valued at $92,655,000 after acquiring an additional 346,449 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is the dip in Micron's stock price a golden buying opportunity or another case of dead money? MarketBeat's Thomas Hughes weighs in, comparing Micron to AMD.

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads